Clinical trial
Effects of (1,3), (1,6)-Beta-D-glucan on Insulin Sensitivity and Inflammatory…
NCT00403689 · German Institute of Human Nutrition, Other · Completed
Key facts
| NCT number | NCT00403689 |
|---|---|
| Title | Effects of (1,3), (1,6)-Beta-D-glucan on Insulin Sensitivity and Inflammatory Markers of the Metabolic Syndrome |
| Official title | Effects of (1,3), (1,6)-Beta-D-glucan on Insulin Sensitivity and Inflammatory Markers of the Metabolic Syndrome |
| Lead sponsor | German Institute of Human Nutrition, Other |
| Collaborators | Danone Research Foundation Leiber Company |
| Status | Completed |
| Study type | Interventional |
| Conditions | Overweight |
| Intervention type | Dietary Supplement |
| Interventions | Beta-D-Glucan, placebo |
| Enrollment | 11 |
| Start date | Nov 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Nov 27, 2006 |
| Last update posted | Aug 5, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: